...
首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution.
【24h】

Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution.

机译:新型碳酸氢盐(25 mmol / L)/乳酸盐(10 mmol / L)腹膜透析液的临床经验。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Physiological bicarbonate/lactate-based solutions may correct acidosis in a better way than standard lactate-based solutions. In this study, a new 25 mmol/L bicarbonate/10 mmol/L lactate peritoneal dialysis (PD) solution was compared with a standard 35 mmolL lactate solution. DESIGN: This was a prospective open label study. All patients had a 2-week baseline period using the standard lactate solution, followed by 8 weeks on the bicarbonate/ lactate solution and 2 weeks on the lactate-based solution. SETTING: Four Danish and four Spanish nephrology centers. PATIENTS: 40 well-dialyzed (creatinine clearance > 55 L/week/1.73 m2 body surface area) patients on continuous ambulatory PD. INTERVENTIONS: Blood samples were taken for biochemistry (including venous blood gases) at week -2, day 1, weeks 2, 4, and 8, and at follow-up. A physical examination, a peritoneal equilibration test (PET), and quality of life (K/DQOL), ultrafiltration, and adequacy assessments were performed at baseline and at week8. Vital signs and other safety parameters were followed at each visit. Extraneal (Baxter Healthcare, Castlebar, Ireland) was used by all patients for the long dwell. MAIN OUTCOME MEASURE: Effect on the venous plasma bicarbonate level. RESULTS: Venous plasma bicarbonate levels rose from 24.4 mmol/L when patients were on the pure lactate to 26.1 mmol/L when using the bicarbonate/lactate solution (p < 0.001). When patients were using the bicarbonate/ lactate solution, 66% of values were maintained within the venous normal range of 24-30 mmol/L, versus 46.2% when patients were on the pure lactate solution (p < 0.001). There were no adverse findings with respect to clinical symptoms, vital signs, or physical examination. The PET and adequacy, ultrafiltration, and K/DQOL assessment results were unchanged. CONCLUSIONS: The new 25 mmol/L bicarbonate/ 10 mmol/L lactate solution provided better correction of acidosis than an equivalent 35 mmol/L standard lactate solution, without any safety issues.
机译:目的:基于生理性碳酸氢盐/乳酸盐的溶液比基于标准乳酸盐的溶液可以更好地纠正酸中毒。在这项研究中,将新的25 mmol / L碳酸氢盐/ 10 mmol / L乳酸腹膜透析(PD)溶液与标准35 mmolL乳酸溶液进行比较。设计:这是一项前瞻性开放标签研究。所有患者均使用标准乳酸盐溶液进行2周的基线治疗,然后在碳酸氢盐/乳酸盐溶液中进行8周,在乳酸盐基溶液中进行2周。地点:四个丹麦和四个西班牙肾脏病中心。患者:40名透析患者(肌酐清除率> 55 L /周/1.73 m2体表面积)连续非卧床PD。干预措施:在第-2周,第1天,第2、4和8周以及随访时采集血样进行生物化学检查(包括静脉血气)。在基线和第8周进行了一次体格检查,腹膜平衡测试(PET)和生活质量(K / DQOL),超滤和充分性评估。每次访视时都要记录生命体征和其他安全参数。所有患者长期使用Extraneal(Baxter Healthcare,Castlebar,爱尔兰)。主要观察指标:对静脉血浆碳酸氢根水平的影响。结果:静脉血浆碳酸氢盐水平从使用纯乳酸盐的患者的24.4 mmol / L上升到使用碳酸氢盐/乳酸盐溶液的26.1 mmol / L(p <0.001)。当患者使用碳酸氢盐/乳酸盐溶液时,其静脉值保持在正常的24-30 mmol / L范围内,而使用纯乳酸盐溶液的患者则保持在46.2%(p <0.001)。没有关于临床症状,生命体征或身体检查的不良发现。 PET和充分性,超滤和K / DQOL评估结果均未改变。结论:新的25 mmol / L碳酸氢盐/ 10 mmol / L乳酸溶液比同等的35 mmol / L标准乳酸溶液可更好地纠正酸中毒,且无任何安全性问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号